NEW YORK (GenomeWeb News) – The University of Cambridge, Genomics England, and Illumina plan to sequence 10,000 whole genomes of children and adults with rare genetic diseases over three years, the organizations said today.

Under the study, called the Rare Diseases Genomes Project, researchers at the University of Cambridge will work with a team at Illumina led by Chief Scientist David Bentley to develop a workflow and processes for bringing routine clinical whole-genome sequencing to patients. Illumina will contribute the sequencing data using its own technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.